KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Liveperson (LPSN) Research & Development (2016 - 2025)

Liveperson (LPSN) has disclosed Research & Development for 16 consecutive years, with $11.5 million as the latest value for Q4 2025.

  • For Q4 2025, Research & Development fell 33.76% year-over-year to $11.5 million; the TTM value through Dec 2025 reached $54.7 million, down 31.43%, while the annual FY2025 figure was $54.7 million, 31.43% down from the prior year.
  • Research & Development hit $11.5 million in Q4 2025 for Liveperson, down from $13.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $56.1 million in Q1 2022 and bottomed at $8.9 million in Q4 2023.
  • Average Research & Development over 5 years is $29.2 million, with a median of $24.6 million recorded in 2024.
  • Year-over-year, Research & Development crashed 75.94% in 2023 and then skyrocketed 93.63% in 2024.
  • Liveperson's Research & Development stood at $45.7 million in 2021, then decreased by 18.73% to $37.1 million in 2022, then plummeted by 75.94% to $8.9 million in 2023, then soared by 93.63% to $17.3 million in 2024, then plummeted by 33.76% to $11.5 million in 2025.
  • According to Business Quant data, Research & Development over the past three periods came in at $11.5 million, $13.4 million, and $13.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.